Nuclear factor-kappa B and cancer: its role in prevention and therapy

This publication has 56 references indexed in Scilit:

• Nuclear transcription factor-κB as a target for cancer drug development
  Leukemia, 2002
• Antiproliferative Effects of IFN-αCorrelate with the Downregulation of Nuclear Factor-κB in Human Burkitt Lymphoma Daudi Cells
  Journal of Interferon & Cytokine Research, 2001
• Making decisions through Myc
  FEBS Letters, 2001
• Wortmannin inhibits activation of nuclear transcription factors NF-κB and activated protein-1 induced by lipopolysaccharide and phorbol ester
  FEBS Letters, 2000
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• Curcumin Causes the Growth Arrest and Apoptosis of B Cell Lymphoma by Downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53
  Clinical Immunology, 1999
• Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
  Oncogene, 1999
• Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-κB
  Leukemia, 1997
• Over-expression ofbcl-xL gene in human gastric adenomas and carcinomas
  International Journal of Cancer, 1996
• Activation of Nuclear Factor κB in Human Lymphoblastoid Cells by Low-Dose Ionizing Radiation
  Radiation Research, 1994